Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?

2Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have checked the vaccination history of 389 elderly patients (62.9% males, mean age of 78.5 + 8.4 years) hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Information regarding pneumococcal vaccination was available for 354 patients (91.0%): the overall vaccination coverage rate (VCR) was 19.8% (70/354), 11.3% received only 13-valent pneumococcal conjugate vaccine (PCV13), 3.4% were immunized with 23-valent pneumococcal polysaccharide vaccine (PPSV23), 5.1% received both vaccines. VCR among the elderly population in Liguria Region was 26.2% (118,581/453,082), among them 13.7% received PCV13, 12.4% were immunized with at least one dose of PPSV23. Regarding the 2019–2020 influenza season vaccination data were available for 46 patients: 59% of them were immunized. VCR in the elderly population was 51.7% (234,153/453,082).

Cite

CITATION STYLE

APA

Sticchi, L., Taramasso, L., Di Biagio, A., Olobardi, D., Icardi, G., & Bassetti, M. (2021). Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? Human Vaccines and Immunotherapeutics. Bellwether Publishing, Ltd. https://doi.org/10.1080/21645515.2020.1829413

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free